These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34147443)

  • 1. Machine Learning of ECG Waveforms to Improve Selection for Testing for Asymptomatic Left Ventricular Dysfunction.
    Potter EL; Rodrigues CHM; Ascher DB; Abhayaratna WP; Sengupta PP; Marwick TH
    JACC Cardiovasc Imaging; 2021 Oct; 14(10):1904-1915. PubMed ID: 34147443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the energy waveform electrocardiogram to detect subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus.
    Soh CH; de Sá AGC; Potter E; Halabi A; Ascher DB; Marwick TH
    Cardiovasc Diabetol; 2024 Mar; 23(1):91. PubMed ID: 38448993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine Learning Assessment of Left Ventricular Diastolic Function Based on Electrocardiographic Features.
    Kagiyama N; Piccirilli M; Yanamala N; Shrestha S; Farjo PD; Casaclang-Verzosa G; Tarhuni WM; Nezarat N; Budoff MJ; Narula J; Sengupta PP
    J Am Coll Cardiol; 2020 Aug; 76(8):930-941. PubMed ID: 32819467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of biomarkers and risk scores with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus.
    Halabi A; Potter E; Yang H; Wright L; Sacre JW; Shaw JE; Marwick TH
    Cardiovasc Diabetol; 2022 Dec; 21(1):278. PubMed ID: 36494683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of Nonischemic Stage B Heart Failure in Type 2 Diabetes Mellitus: Optimal Parameters for Prediction of Heart Failure.
    Wang Y; Yang H; Huynh Q; Nolan M; Negishi K; Marwick TH
    JACC Cardiovasc Imaging; 2018 Oct; 11(10):1390-1400. PubMed ID: 29778859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening-guided spironolactone treatment of subclinical left ventricular dysfunction for heart failure prevention in at-risk patients.
    Potter E; Stephenson G; Harris J; Wright L; Marwick TH
    Eur J Heart Fail; 2022 Apr; 24(4):620-630. PubMed ID: 35014128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure.
    Motoki H; Borowski AG; Shrestha K; Troughton RW; Tang WH; Thomas JD; Klein AL
    J Am Coll Cardiol; 2012 Nov; 60(20):2074-81. PubMed ID: 23083779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic ability of B-type natriuretic peptide and impedance cardiography: testing to identify left ventricular dysfunction in hypertensive patients.
    Bhalla V; Isakson S; Bhalla MA; Lin JP; Clopton P; Gardetto N; Maisel AS
    Am J Hypertens; 2005 Feb; 18(2 Pt 2):73S-81S. PubMed ID: 15752936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
    Tarantini L; Cioffi G; Di Lenarda A; Valle R; Pulignano G; Del Sindaco D; Frigo G; Soravia G; Tessier R; Catania G
    G Ital Cardiol (Rome); 2008 Dec; 9(12):835-43. PubMed ID: 19119693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-specific diastolic dysfunction improves prediction of symptomatic heart failure by Stage B heart failure.
    Coller JM; Gong FF; McGrady M; Jelinek MV; Castro JM; Boffa U; Shiel L; Liew D; Stewart S; Krum H; Reid CM; Prior DL; Campbell DJ
    ESC Heart Fail; 2019 Aug; 6(4):747-757. PubMed ID: 31094087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independence of coronary artery disease to subclinical left ventricular dysfunction.
    Venkataraman P; Wright L; Huynh Q; Marwick TH
    Echocardiography; 2020 May; 37(5):678-687. PubMed ID: 32315491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automatic Detection of Left Ventricular Dilatation and Hypertrophy from Electrocardiograms Using Deep Learning.
    Kokubo T; Kodera S; Sawano S; Katsushika S; Nakamoto M; Takeuchi H; Kimura N; Shinohara H; Matsuoka R; Nakanishi K; Nakao T; Higashikuni Y; Takeda N; Fujiu K; Daimon M; Akazawa H; Morita H; Matsuyama Y; Komuro I
    Int Heart J; 2022 Sep; 63(5):939-947. PubMed ID: 36104234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular diastolic function, assessed by echocardiography and tissue Doppler imaging, is a strong predictor of cardiovascular events, superior to global left ventricular longitudinal strain, in patients with type 2 diabetes.
    Blomstrand P; Engvall M; Festin K; Lindström T; Länne T; Maret E; Nyström FH; Maret-Ouda J; Östgren CJ; Engvall J
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):1000-7. PubMed ID: 25750201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial and left ventricular diastolic function in chronic Chagas disease.
    Nascimento CA; Gomes VA; Silva SK; Santos CR; Chambela MC; Madeira FS; Holanda MT; Brasil PE; Sousa AS; Xavier SS; Hasslocher-Moreno AM; Cunha AB; Saraiva RM
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1424-33. PubMed ID: 24055123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction With the Use of Electrocardiographic Artificial Intelligence: A Cost-Effectiveness Approach.
    Liu WT; Hsieh PH; Lin CS; Fang WH; Wang CH; Tsai CS; Hung YJ; Hsieh CB; Lin C; Tsai DJ
    Can J Cardiol; 2024 Jul; 40(7):1310-1321. PubMed ID: 38092190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction and pre-clinical (stage B) heart failure in the elderly. Results from 'PREDICTOR', a population based-study in central Italy.
    Mureddu GF; Tarantini L; Agabiti N; Faggiano P; Masson S; Latini R; Cesaroni G; Miceli M; Forastiere F; Scardovi AB; Uguccioni M; Boccanelli A
    Eur J Heart Fail; 2013 Oct; 15(10):1102-12. PubMed ID: 23787717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Abnormal Myocardial Relaxation From Signal Processed Surface ECG.
    Sengupta PP; Kulkarni H; Narula J
    J Am Coll Cardiol; 2018 Apr; 71(15):1650-1660. PubMed ID: 29650121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA study.
    Cioffi G; Giorda CB; Chinali M; Di Lenarda A; Faggiano P; Lucci D; Maggioni AP; Masson S; Mureddu GF; Tarantini L; Velussi M; Comaschi M;
    Eur J Prev Cardiol; 2012 Oct; 19(5):935-43. PubMed ID: 21798988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.